ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
Diagnostic Model for Obesity and Type 2 Diabetes Mellitus Based on Feature Selection from Fatty Acids, Amino Acids, and Clinical Characteristics.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Given that obesity and type 2 diabetes mellitus (T2DM) share complicated pathophysiological mechanisms, this study aimed to establish a diagnostic model for the two diseases using feature selection from fatty acids, amino acids, and clinical characteristics. Methods: This prospective study included 81 obese patients, 25 T2DM patients and 33 healthy controls. Amino acids and fatty acids in serum were tested using LC-MS/MS method. Anthropometric and laboratory measurements were recorded. All samples were split into a training set and a test set (7/3 ratio). Results: Total 54 variables were significantly different between obesity, T2DM and control groups (p-value < 0.05). In uni-variable logistic regression analysis, 44 variables were significantly associated with disease diagnosis. LASSO, RFE and RF algorithms jointly selected 7 optimal variables (Ala, His, Gln, IL-10, age, FBG, and AHR). The support vector machine (SVM) diagnostic model based on the 7 variables showed robust performance in both the training set (AUC = 0.998) and the validation set (AUC = 0.958). Obesity or T2DM patients had significantly increased Ala (p-value < 0.01) but decreased Gln, His and IL-10 (p-value < 0.01) in serum compared to healthy controls. Gln and His levels were positively correlated with IL-10 level (Cor = 0.46, 0.48, p-value < 0.001). Conclusion: This study developed a 7 feature-based diagnostic model for obesity and T2DM and suggested that Ala, His, Gln, and IL-10 were involved in the common mechanisms and might be potential therapeutic targets.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.